Nov 5, 6:15 AM ET
The Cigna Group reported third-quarter 2026 total revenues of $73.7 billion and shareholders' net income of $1.4 billion, or $5.47 per share. Driven by strong segment execution, the company raised its full-year 2026 adjusted income from operations outlook to at least $30.60 per share.
- Total revenues for the third quarter of 2026 increased 6% year-over-year to $73.7 billion.
- Shareholders' net income for the third quarter of 2026 was $1.4 billion, or $5.47 per share.
- Full-year 2026 adjusted income from operations outlook was raised to at least $30.60 per share.
- The company repurchased 1.8 million shares of common stock for approximately $500 million through November 4, 2026.
Read the filing on SEC.gov ↗
Oct 9, 4:15 PM ET
Cigna Group said director Donna F. Zarcone informed the Board on October 6, 2026, that she will retire effective December 31, 2026. The company stated her retirement is not the result of any disagreement with the company.
- Donna F. Zarcone notified the Board of her retirement on October 6, 2026.
- Retirement takes effect December 31, 2026.
- The company said the retirement is not due to any disagreement with Cigna.
- Filing was signed by Andrea Nelson, General Counsel and Corporate Secretary, on October 9, 2026.
Read the filing on SEC.gov ↗
Jul 30, 6:16 AM ET
The Cigna Group reported second quarter 2026 results, with total revenues up 7% to $71.7 billion and shareholders' net income of $1.7 billion, or $6.29 per share, versus $5.71 a year earlier. Adjusted income from operations rose 6% to $2.1 billion, or $7.78 per share, and the company raised its full-year 2026 adjusted per-share outlook to at least $30.45, an increase of $0.10. For shareholders, the higher outlook and improved headline profit are offset in part by a sharp drop in Pharmacy Benefit Services profit.
- Total revenues rose 7% to $71.7 billion; shareholders' net income was $1.7 billion, or $6.29 per share, compared with $1.5 billion, or $5.71 per share, in Q2 2025.
- Adjusted income from operations was $2.1 billion, or $7.78 per share, compared with $7.20 per share in Q2 2025.
- Full-year 2026 adjusted income from operations outlook increased to at least $30.45 per share, up $0.10 from the prior projection.
- Pharmacy Benefit Services adjusted pre-tax income fell 27% year over year, while Cigna Healthcare adjusted pre-tax income rose 17%.
Read the filing on SEC.gov ↗
Apr 30, 6:15 AM ET
The Cigna Group reported first quarter 2026 results on April 30, 2026, with total revenues up 5% to $68.5 billion and shareholders' net income of $1.7 billion, or $6.26 per share, versus $1.3 billion, or $4.85 per share, a year earlier. It raised its full-year 2026 adjusted income from operations outlook to at least $30.35 per share, up $0.10, which points to higher expected per-share earnings for shareholders. Within Evernorth, Pharmacy Benefit Services adjusted pre-tax income fell 28%, while Cigna Healthcare adjusted pre-tax income rose 18%.
- Total revenues rose 5% to $68.5 billion for the quarter ended March 31, 2026.
- Shareholders' net income was $1.7 billion, or $6.26 per share, versus $1.3 billion, or $4.85 per share, in Q1 2025.
- Adjusted income from operations was $2.1 billion, or $7.79 per share, versus $6.74 per share in Q1 2025.
- 2026 adjusted income from operations outlook is at least $30.35 per share, a $0.10 increase; Pharmacy Benefit Services adjusted pre-tax income fell 28%.
Read the filing on SEC.gov ↗
Briefs are written by AI from the filing text (each brief's own page names the model) and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the model's reading of the filing for shareholders, not a price forecast. Not investment advice.
